"
| Currently in synthetic biology, the creation of novel genetic circuits revolves around a familiar design-build-test cycle. As an increasing number of laboratories become involved in designing newer and more sophisticated constructs, the lack of standardization in production and characterization inhibits workflow efficiency and, by extension, growth of the field. The 2014 Boston University iGEM team seeks to employ a formalized and optimized workflow supported by new bio-design automation applications, with the aim of benefiting synthetic biologists seeking to more efficiently design, build, and characterize complex constructs.
Advancements in bio-design automation (or BDA) have allowed for the implementation of a variety of software and automation tools that help improve the efficiency in a synthetic biology laboratory. We will take a novel approach to the design-build-test cycle by using software tools to formalize our workflows, thus making us one of the first BDA iGEM teams. We will supplement the CIDAR MoClo basic parts library (built by the 2012 and 2013 BU iGEM teams) with hybrid promoters, fusion proteins, and a variety of new destination vectors. With these modular parts, we will build complex constructs using our formalized workflow, in addition to providing comprehensive characterization data for all new parts and improving data for existing parts in the Registry of Standard Biological Parts. Our BDA approach will include utilizing various software tools throughout the design-build-test cycle in our wet lab work, including Eugene, Raven, and the TASBE Tools for flow cytometry. | |
|---|---|
|
|
|
Team:BostonU
From 2014.igem.org
(Difference between revisions)
| Line 29: | Line 29: | ||
<ul id="nav"> | <ul id="nav"> | ||
<li><a href="https://2014.igem.org/Team:BostonU/Team">TEAM</a> | <li><a href="https://2014.igem.org/Team:BostonU/Team">TEAM</a> | ||
| - | |||
| - | |||
| - | |||
| - | |||
</li> | </li> | ||
<li><a href="">PROJECT</a> | <li><a href="">PROJECT</a> | ||
<ul> | <ul> | ||
<li><a href="https://2014.igem.org/Team:BostonU/Chimera">Overview</a></li> | <li><a href="https://2014.igem.org/Team:BostonU/Chimera">Overview</a></li> | ||
| + | <li><a href="https://2014.igem.org/Team:BostonU/MoClo">MoClo Assembly Method</a></li> | ||
<li><a href="https://2014.igem.org/Team:BostonU/Backbones">Backbones</a></li> | <li><a href="https://2014.igem.org/Team:BostonU/Backbones">Backbones</a></li> | ||
<li><a href="https://2014.igem.org/Team:BostonU/ProjectTandemPromoters">Tandem Promoters</a></li> | <li><a href="https://2014.igem.org/Team:BostonU/ProjectTandemPromoters">Tandem Promoters</a></li> | ||
<li><a href="https://2014.igem.org/Team:BostonU/FusionProteins">Fusion Proteins</a></li> | <li><a href="https://2014.igem.org/Team:BostonU/FusionProteins">Fusion Proteins</a></li> | ||
| - | |||
<li><a href="https://2014.igem.org/Team:BostonU/FlowCytometry">Flow Cytometry</a></li> | <li><a href="https://2014.igem.org/Team:BostonU/FlowCytometry">Flow Cytometry</a></li> | ||
</ul> | </ul> | ||
| Line 67: | Line 63: | ||
<li><a href="https://2014.igem.org/Team:BostonU/Interlab">Interlab Study</a></li> | <li><a href="https://2014.igem.org/Team:BostonU/Interlab">Interlab Study</a></li> | ||
<li><a href="https://2014.igem.org/Team:BostonU/NEGEM">NEGEM</a></li> | <li><a href="https://2014.igem.org/Team:BostonU/NEGEM">NEGEM</a></li> | ||
| - | <li><a href="https://2014.igem.org/Team:BostonU/HumanPractices"> | + | <li><a href="https://2014.igem.org/Team:BostonU/HumanPractices">Policy and Practices</a></li> |
</ul> | </ul> | ||
<li><a href="https://2014.igem.org/Team:BostonU/Acknowledgements">ACKNOWLEDGEMENTS</a> | <li><a href="https://2014.igem.org/Team:BostonU/Acknowledgements">ACKNOWLEDGEMENTS</a> | ||
Revision as of 17:22, 18 September 2014
